AJANTA PHARMA LTD.

NSE : AJANTPHARMBSE : 532331ISIN CODE : INE031B01049Industry : Pharmaceuticals & DrugsHouse : Vimal Agrawal
BSE1439.1017.85 (+1.26 %)
PREV CLOSE ( ) 1421.25
OPEN PRICE ( ) 1427.85
BID PRICE (QTY) 1437.15 (86)
OFFER PRICE (QTY) 1439.80 (71)
VOLUME 7795
TODAY'S LOW / HIGH ( )1422.00 1455.00
52 WK LOW / HIGH ( )1106 1870
NSE1438.4518.65 (+1.31 %)
PREV CLOSE( ) 1419.80
OPEN PRICE ( ) 1430.45
BID PRICE (QTY) 1438.30 (90)
OFFER PRICE (QTY) 1438.45 (50)
VOLUME 175369
TODAY'S LOW / HIGH( ) 1418.20 1458.30
52 WK LOW / HIGH ( )1120.05 1871.95
BSE
1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Incorporation Year : 31-12 1979
Management Info
Mannalal B Agrawal - Chairman Yogesh M Agrawal - Managing Director
Registered Office

Address Ajanta House,Charkop ,Kandivali (W),
Mumbai,
Maharashtra-400067

Phone 91-22-66061000

Email info@ajantapharma.com

Website www.ajantapharma.com

Registrars Details
Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS
22Nov NCC, Ajanta Pharma and Virinchi to see
The consortium formed between NCC & BGR Infra has been awarded the p..
21Nov Ajanta Pharma launches Clonidine Hydro
Ajanta Pharma has launched Clonidine Hydrochloride Extended Release Tabl..
21Nov Ajanta Pharma gains on launching Cloni
Ajanta Pharma is currently trading at Rs. 1343.00, up by 6.80 points or..
21Nov Press Release / Media Release
We are pleased to inform you that we have received the final approval fo..
31Oct Outcome of Board Meeting
At the Board meeting held today, the Board has inter alia approved and t..
Financials
Rs. in Millions
QTR Sep 17 ANNUAL 17
Net Profit10774998.1
Gross Profit 1513.7 6406.5
Operating Profit 1653.77029.6
Net Sales 4691.418227.1
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group
Dr. Reddys Lab (BSE)
 2301.50 (1.80%)
M.Cap (Rs. in Cr)38158.22
Natco Pharma (BSE)
 1002.00 (4.12%)
M.Cap (Rs. in Cr)17492.15
Wockhardt (BSE)
 751.10 (4.12%)
M.Cap (Rs. in Cr)8322.41
Piramal Enterprises (BSE)
 2732.85 (0.34%)
M.Cap (Rs. in Cr)47074.39
Divis Lab (BSE)
 1049.45 (0.88%)
M.Cap (Rs. in Cr)27768.01
Shareholding Pattern
PROMOTERS 70.7%
NON-INSTITUTION 11.67%
MUTUAL FUNDS/UTI 5.09%
FI/BANKS/INSURANCE 0.22%
GOVERNMENT 0%
FII 0%
ATTENTION INVESTORSKYCIPO
REGISTRATION NOS.

NSE CM-INB231215030|NSE F& O - INF231215030, NSE CD-INE231215030, BSE CM–INB011215036 |BSE F & O - INF011215036 MCX-SX CM-INB261215033|MCX-SX F & O - INF261215033|MCX-SX CD-INE261215033 NSDL - IN-DP-NSDL-319-2009ROC REG - 21-097912

INVESTOR PROTECTION

Compliance officer : Aishwarya M. Kalal, Tel no: 022-40790032, Mobile no- 9773104340, E-mail id- Complaince@nnmsecurities.com

Investor grievance : support@nnmsecurities.com

Copyright © 2016 NNM Securities.com

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.